67 results
8-K
EX-99.2
HRTX
Heron Therapeutics Inc
19 Sep 22
Other Events
8:00am
. doi:10.1213/01.ane.0000263277.35140.a3. 3. APONVIE [package insert]. San Diego, CA: Heron Therapeutics Inc; 2022. 4. EMEND [package insert … INFORMATION at the end of this presentation 19
Establish Heron as a Leader in Acute Care References: 1. ZYNRELEF [package insert]. San Diego, CA: Heron
8-K
EX-99.1
y05asp34
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am
8-K
EX-99.2
xgekyd
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.2
3v8m13u3stt76cp3r4b
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am